ASCO Annual Meeting 2025
At this year’s American Society of Clinical Oncology Annual Meeting (ASCO), we will be sharing the latest oncology portfolio data, research, and science around how we are reimagining medicine.
Discover our medicines
See how our innovative medicines are addressing society's greatest health challenges.
Commitment to patients
From research and development to expanding access, uncover our commitment to improving people's lives.
Inspired by purpose
Learn about our people and culture, and how we're driven by our mission to reimagine medicine.
Novartis Financial Results - Q1 2025
Novartis announced the company’s financial results for the first quarter of 2025.
Latest News
Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis
New Novartis data at ASCO and EHA showcase momentum of pioneering portfolio with promising pipeline
